Pharma / Biotech

Cost of Praluent PCSK9 Inhibitor Lowered for Medicare Patients

The cost of Praluent, regardless of dose, will be $5,850 annually, a 60% reduction from the original price.

Source link

Related posts

FDA Approves Nivestym, Second Biosimilar of Neupogen


CHILDRENS ACETAMINOPHEN (Acetaminophen) Suspension [Pharmaceutical Associates, Inc.]


clinical pharmacology; +110 new citations


This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy